Skip to main content
Premium Trial:

Request an Annual Quote

Panomics Opens European Subsidiary in Italy

NEW YORK, April 25 (GenomeWeb News) - Reagent company Panomics today said it has opened a wholly owned European subsidiary, Panomics SRL, located in Milan, Italy.

 

"There is substantial customer demand for Panomics' products in Europe," George Bers, executive vice president for commercial operations at Panomics, said in a statement.

 

Bio-Rad alumni Luigi Pirovano has been named managing director of the new unit.

 

Panomics is a provider of research reagents for transcription regulation, cell signaling, and signal transduction. As GenomeWeb News reported, Genospectra acquired Panomics  in February.

 

The combined company, which was renamed Panomics, plays in markets including cell signaling, RNAi-mediated gene silencing and high performance assays, clinical biomarker discovery, and predictive toxicology.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.